STTK
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Aug 28, 04:19 PM (EDT)
Capitalization
47.9M
75 days until earnings call
VRTX
Price
$392.12
Change
+$3.04 (+0.78%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
99.27B
62 days until earnings call
Interact to see
Advertisement

STTK vs VRTX

Header iconSTTK vs VRTX Comparison
Open Charts STTK vs VRTXBanner chart's image
Shattuck Labs
Price$1.00
Change-$0.00 (-0.00%)
Volume$300
Capitalization47.9M
Vertex Pharmaceuticals
Price$392.12
Change+$3.04 (+0.78%)
Volume$8.16K
Capitalization99.27B
STTK vs VRTX Comparison Chart in %
Loading...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STTK vs. VRTX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STTK is a Hold and VRTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (STTK: $1.00 vs. VRTX: $389.08)
Brand notoriety: STTK and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STTK: 5% vs. VRTX: 111%
Market capitalization -- STTK: $47.9M vs. VRTX: $99.27B
STTK [@Biotechnology] is valued at $47.9M. VRTX’s [@Biotechnology] market capitalization is $99.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STTK’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 0 green FA rating(s).

  • STTK’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VRTX is a better buy in the long-term than STTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STTK’s TA Score shows that 4 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • STTK’s TA Score: 4 bullish, 4 bearish.
  • VRTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both STTK and VRTX are a good buy in the short-term.

Price Growth

STTK (@Biotechnology) experienced а -0.99% price change this week, while VRTX (@Biotechnology) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.32%. For the same industry, the average monthly price growth was +14.92%, and the average quarterly price growth was +30.67%.

Reported Earning Dates

STTK is expected to report earnings on Nov 11, 2025.

VRTX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($99.3B) has a higher market cap than STTK($47.9M). VRTX YTD gains are higher at: -3.382 vs. STTK (-17.355). VRTX has higher annual earnings (EBITDA): 4.59B vs. STTK (-61.22M). VRTX has more cash in the bank: 6.38B vs. STTK (50.5M). STTK has less debt than VRTX: STTK (2.97M) vs VRTX (1.53B). VRTX has higher revenues than STTK: VRTX (11.4B) vs STTK (3M).
STTKVRTXSTTK / VRTX
Capitalization47.9M99.3B0%
EBITDA-61.22M4.59B-1%
Gain YTD-17.355-3.382513%
P/E RatioN/A27.67-
Revenue3M11.4B0%
Total Cash50.5M6.38B1%
Total Debt2.97M1.53B0%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STTKVRTX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 8 days ago
60%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 3 days ago
41%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
53%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGKKF4.30N/A
N/A
Bangkok Bank Public Co Ltd.
KNX44.23-0.23
-0.52%
Knight-Swift Transportation Holdings
JSPR2.90-0.02
-0.68%
Jasper Therapeutics
LASR28.76-0.34
-1.17%
nLIGHT
AMCX6.99-0.16
-2.24%
AMC Networks

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-1.96%
ACAD - STTK
39%
Loosely correlated
+3.30%
LSB - STTK
38%
Loosely correlated
-2.80%
VRTX - STTK
36%
Loosely correlated
+0.49%
ADCT - STTK
35%
Loosely correlated
+1.58%
NAUT - STTK
32%
Poorly correlated
-0.50%
More